The aim of the study was to evaluate the possibility of detecting thyroid cancer recurrences without the need for withdrawal of thyroid suppressive treatment. Upper-body or whole-body scintigraphy was performed in a group of 200 patients evaluated for differentiated thyroid cancers in 1993 and 1994 using technetium-99m sestamibi. Scans were performed 20-30min following i.v. administration of 500MBq of 99mTc-methoxyisobutylisonitrile (MIBI). Bone and lung metastases were detected with very high sensitivity and specificity, with a very high predictive value of negative results and a somewhat lower predictive value of positive results. The sensitivity and specificity of findings in the neck were lower but the predictive value of negative results was high. Whole-body scans with 99mTc-MIBI are a useful tool in the follow-up of patients with differentiated thyroid cancer, for the detection of distant metastatic lesions.

Clinic of Nuclear Medicine 2nd Medical School Charles University Institute of Endocrinology 150 18 Praha 5 Motol Czech Republic

See more in PubMed

J Nucl Biol Med. 1992 Oct-Dec;36(4):315-8 PubMed

Ann Acad Med Singapore. 1993 Jul;22(4):557-9 PubMed

Nucl Med Commun. 1995 Aug;16(8):694-7 PubMed

J Nucl Med. 1993 Jan;34(1):71-4 PubMed

J Nucl Med. 1979 Feb;20(2):92-7 PubMed

Eur J Nucl Med. 1994 Sep;21(9):980-3 PubMed

Nuklearmedizin. 1991 Aug;30(4):115-24 PubMed